An Alternative Therapy for Patients with Hepatic Impairment?

Publisher： Karger

E-ISSN： 2296-5262|30|10|474-475

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.30, Iss.10, 2007-09, pp. : 474-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 10, 2015-10 ,pp. : 1147-1156

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapy of intracranial hypertension in patients with fulminant hepatic failure

By Raghavan Murugan   Marik Paul  

Neurocritical Care, Vol. 4, Iss. 2, 2006-04 ,pp. : 179-189

Humana Press, Inc

Access to resources Recommend Favorite

Pharmacokinetics of serelaxin in patients with hepatic impairment: a single‐dose, open‐label, parallel group study

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 6, 2015-06 ,pp. : 937-945

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 357-363

John Wiley & Sons Inc

Access to resources Recommend Favorite

Psychosocial Characterization of Patients with Atopic Dermatitis in Conventional versus Alternative-Medical Therapy

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 6, Iss. 2, 2004-11 ,pp. : 22-25

Karger

Access to resources Recommend Favorite